StoxSai Parenterals Limited
NSE: SAIPARENT · Unclassified
Ask the data
Instant answers about Sai Parenterals Limited — computed from its filings, no language modelPrice & valuation
split & bonus adjusted · pick a metric and rangeAnnual performance
annual · ₹ crore · line = operating margin| FY26 | |
|---|---|
| Revenue | 381.0 |
| EBITDA | 38.7 |
| Operating margin | 10.2% |
| Interest | 18.4 |
| Depreciation | 16.9 |
| Profit before tax | 11.9 |
| Tax | -2.3 |
| Net profit | 14.3 |
| EPS ₹ | 4.36 |
| Operating cash flow | 93.0 |
| Capex | 65.5 |
| Dividend paid | 0.0 |
| Total assets | 1,424.2 |
| Equity | 490.8 |
Quarterly performance
last 4 quarters · ₹ crore| DEC '25 | MAR '26 | JUN '26 | SEP '26 | |
|---|---|---|---|---|
| Revenue | 96.2 | 197.9 | 178.7 | 194.9 |
| Operating profit | -3.6 | 26.1 | 23.5 | 40.2 |
| Operating margin | -3.7% | 13.2% | 13.2% | 20.6% |
| Other income | 3.1 | 2.9 | 3.7 | 3.7 |
| Interest | 5.4 | 8.4 | 9.4 | 9.0 |
| Depreciation | 5.8 | 8.2 | 8.1 | 25.1 |
| Profit before tax | -11.6 | 12.4 | 9.8 | 9.9 |
| Tax | -5.0 | -0.8 | 1.9 | -0.6 |
| Net profit | -6.7 | 13.2 | 0.0 | 0.0 |
| EPS ₹ | -2.22 | 4.02 | 1.79 | 2.38 |
Returns & margins
trailing-twelve-month, per quarter| SEP '26 | |
|---|---|
| ROE | 1.3% |
| ROCE | 6.2% |
| Net margin | 1.0% |
| EBITDA margin | 12.9% |
| Debt / equity | 0.72 |
| Interest coverage | 1.64 |
| Asset turnover | 0.51 |
Balance sheet
equity vs borrowings over time · ₹ crore| MAR '26 | SEP '26 | |
|---|---|---|
| Share capital | 22.1 | 22.1 |
| Other equity / reserves | 468.7 | 473.7 |
| Total equity | 490.8 | 495.8 |
| Borrowings | 319.5 | 356.6 |
| Current liabilities | 572.6 | 464.1 |
| Non-current liabilities | 356.5 | 347.6 |
| Total assets | 1,424.2 | 1,319.8 |
| Property, plant & equipment | 61.6 | 82.6 |
| Capital work-in-progress | 212.2 | 269.3 |
| Investments | 0.0 | 0.0 |
| Inventories | 171.8 | 182.2 |
| Receivables | 181.0 | 254.5 |
| Cash & equivalents | 417.0 | 129.3 |
Cash flow
annual · ₹ crore · line = free cash flow| FY26 | |
|---|---|
| Cash from operations | 93.0 |
| Cash from investing | -273.8 |
| Cash from financing | 595.6 |
| Capex | 65.5 |
| Free cash flow | 27.6 |
| Dividends paid | 0.0 |
Where the assets sit
Sep '26 · ₹ crorePeer comparison
largest in Unclassified · this company in bold| Company | Market cap ₹cr | Price | P/E | P/B | ROE |
|---|---|---|---|---|---|
| Avantel Limited | 36,86,04,549 | 138.69 | — | 1059360.68 | 0.0% |
| Ducol Organics And Colours Limited | 19,55,275 | 120.00 | — | 20089.13 | 0.0% |
| Jio Platforms Limited | 12,57,181 | 1,406.40 | — | 3.57 | — |
| SBI Funds Management Limited | 1,01,750 | 499.55 | — | — | — |
| Tamilnadu Telecommunication Limited | 91,314 | 9.93 | — | — | — |
| Manipal Health Enterprises Limited | 76,294 | 646.70 | — | — | — |
| INDO-MIM Limited | 59,042 | 1,219.50 | — | — | — |
| AvenuesAI Limited | 45,138 | 129.25 | 153.6 | 9.51 | 6.2% |
| Dhoot Transmission Limited | 32,761 | 1,601.60 | — | 8.11 | — |
| 3M India Limited | 31,071 | 27,570.00 | 53.8 | 17.57 | 32.7% |
| Sai Parenterals Limited | 1,527 | 466.35 | 234.9 | 3.08 | 1.3% |
StoxGud checklist: Bearish setup · 2/10
- Price above 50-day average
- Price above 200-day average
- 50-day average above 200-day (uptrend)
- RSI in healthy 40–70 zone
- Positive 1-year return
- Return on equity above 15%
- Debt to equity below 1
- Revenue growing year on year
- Net profit margin above 10%
- P/E below industry median
A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.
Returns & technicals
FAQs
What is the share price of Sai Parenterals Limited?
Sai Parenterals Limited (SAIPARENT) closed at ₹466.35 on NSE on 06 Nov 2026.
What is the market cap of Sai Parenterals Limited?
₹1,527 crore at the latest close.
What is the P/E ratio of Sai Parenterals Limited?
234.9, on trailing-twelve-month earnings from its filings.
How fast is Sai Parenterals Limited growing?
Not enough filed history yet to measure Sai Parenterals Limited's growth.
How profitable is Sai Parenterals Limited?
On a trailing-twelve-month basis return on equity is 1.3%, return on capital employed 6.2%, operating margin 12.9%, net margin 1.0%.
How much debt does Sai Parenterals Limited have?
Sai Parenterals Limited is moderately geared: debt to equity is 0.72 with borrowings of ₹357 cr against cash of ₹129 cr (balance sheet of 2026-09-30). Operating profit covers interest 1.6 times.
Financials parsed from Sai Parenterals Limited's own XBRL filings to NSE (consolidated), ₹ crore unless marked. Quarterly from DEC '25, annual from FY26, balance sheet from Mar '26. * = derived (full year or half year minus earlier quarters). Information only, not investment advice.